Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen

Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen

ObjectivesTo describe the clinical characteristics and outcomes of adult macrophage activation syndrome (MAS) patients and to provide experience for the treatment.MethodsAdult patients with MAS admitted to Beijing Friendship Hospital from December 2014 to September 2021 were enrolled in this study....

Full description

Bibliographic Details
Main Authors:	Lingbo He, Shuyan Yao, Ruoxi Zhang, Menghan Liu, Zhengjie Hua, Heshan Zou, Zhao Wang, Yini Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Immunology
Subjects:	hemophagocytic lymphohistiocytosis (HLH) macrophage activation syndrome (MAS) autoimmune disease (AID) cytokine etoposide adult
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.955523/full

Similar Items

Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients
by: Shuyan Yao, et al.
Published: (2023-12-01)

The role of etoposide in the treatment of adult patients with hemophagocytic lymphohistiocytosis
by: Timo C. E. Zondag, et al.
Published: (2023-01-01)

The efficacy and safety of chidamide in combination with etoposide and glucocorticoids for the treatment of hemophagocytic lymphohistiocytosis in adult patients: an open-label, single-center study
by: Junxia Hu, et al.
Published: (2024-07-01)

Requirement for etoposide in the treatment of pregnancy related hemophagocytic lymphohistiocytosis: a multicenter retrospective study
by: Yue Song, et al.
Published: (2019-02-01)

Adult-Onset Still’s Disease (AOSD)—On the Basis of Own Cases
by: Małgorzata Wisłowska
Published: (2024-09-01)

Patients with Hemophagocytic Lymphohistiocytosis Who Need Intensive Care Can Be Successfully Rescued by Timely Using Etoposide-Based HLH Regimens
by: Lv K, et al.
Published: (2024-02-01)

Etoposide‐based treatment of adult HLH is associated with high biochemical response but poor survival outcomes
by: Matthew C. Nicholson, et al.
Published: (2020-07-01)

Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis
by: Ellen Brisse, et al.
Published: (2017-12-01)

Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)
by: Robert David Sandler, et al.
Published: (2020-03-01)

Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore
by: Cornelia Knaak, et al.
Published: (2020-05-01)

Lymphohistiocyosis
by: Prabhat Agrawal, et al.
Published: (2017-01-01)

Central nervous system involvement and thrombocytopenia as predictors of mortality in children with hemophagocytic lymphohistiocytosis
by: Saralee Harnchoowong, et al.
Published: (2022-09-01)

Deciphering the clinical profile and diagnostic framework of hemophagocytic lymphohistiocytosis in a tertiary care setting
by: Lipsa Priyadarshini, et al.
Published: (2024-12-01)

Hemophagocytic lymphohistiocytosis secondary to dengue fever
by: Simon Kashfi, et al.
Published: (2025-02-01)

A Novel Engineering Cell Therapy Platform Mimicking the Immune Thrombocytopenia‐Derived Platelets to Inhibit Cytokine Storm in Hemophagocytic Lymphohistiocytosis
by: Zhenyu Liu, et al.
Published: (2024-12-01)

Early identification of macrophage activation syndrome in adult-onset Still’s disease: a case report and literature review
by: Ting Long, et al.
Published: (2025-01-01)

Presentations and outcomes of familial hemophagocytic lymphohistiocytosis in the pediatric intensive care units (PICUs)
by: Fahad Alsohime, et al.
Published: (2023-04-01)

Macrophage activation syndrome in a patient with systemic lupus erythematous triggered by tuberculous meningitis
by: Noura Alowais, et al.
Published: (2024-12-01)

Comprehensive insights into tuberculosis-associated hemophagocytic lymphohistiocytosis: a systematic review
by: Arvin Eslami, et al.
Published: (2024-11-01)

Hemophagocytic Lymphohistiocytosis as Initial Presentation of Malignancy in Pediatric Patients: Rare but Not to Be Ignored
by: Hye-ji Han, et al.
Published: (2021-11-01)

Genetic background of primary and familial HLH in Qatar: registry data and population study
by: Elkhansa Elgaali, et al.
Published: (2024-05-01)

Hemophagocytic lymphohistiocytosis: pediatric hepatic perspective
by: Manal Hamdy El-Sayed, et al.
Published: (2024-10-01)

IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome
by: Etienne Dufranc, et al.
Published: (2020-04-01)

Editorial: Towards a better understanding of hemophagocytic lymphohistiocytosis
by: Sabrin Albeituni
Published: (2024-04-01)

Familial Hemophagocytic Lymphohistiocytosis secondary to UNC13D mutation: a report of two cases
by: Payman Sadeghi, et al.
Published: (2022-11-01)

Wolman disease presenting with hemophagocytic lymphohistiocytosis syndrome and a novel LIPA gene variant: a case report and review of the literature
by: Kosar Asna Ashari, et al.
Published: (2023-08-01)

A mild, self-resolving case of Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis
by: Biplov Adhikari, et al.
Published: (2022-01-01)

Macrophage activation syndrome in systemic lupus erythematosus - a case report
by: Maciej Rogala, et al.
Published: (2023-08-01)

Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: response to HLH-04 treatment protocol
by: Elva Jiménez-Hernández, et al.
Published: (2016-01-01)

Etoposide treatment in secondary hemophagocytic syndrome: impact on healthcare-associated infections and survival
by: Thibault Dupont, et al.
Published: (2022-10-01)

Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report
by: Wesam Gouda, et al.
Published: (2021-10-01)

Case Report: Parvovirus B19 infection complicated by hemophagocytic lymphohistiocytosis in a heart-lung transplant patient
by: Xuewu Zhang, et al.
Published: (2023-02-01)

Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure
by: Jonathan Paolino, et al.
Published: (2022-10-01)

Insights into the cellular pathophysiology of familial hemophagocytic lymphohistiocytosis
by: Erica A. Steen, et al.
Published: (2023-03-01)

PEG-aspargase and DEP regimen combination therapy for refractory Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis
by: Jingshi Wang, et al.
Published: (2016-09-01)

Hemophagocytic Lymphohistiocytosis (HLH) in Patients with Tick-Borne Illness: A Scoping Review of 98 Cases
by: Dorde Jevtic, et al.
Published: (2024-02-01)

Case report: A cyclic neutropenia patient with ELANE mutation accompanied by hemophagocytic lymphohistiocytosis
by: Lang Yu, et al.
Published: (2024-11-01)

Human adenovirus infection with secondary hemophagocytic lymphohistiocytosis in immunocompromised children in clusters from South India
by: Sudeep Gaddam, et al.
Published: (2024-12-01)

GATA2 deficiency and hemophagocytic lymphohistiocytosis (HLH): a systematic review of reported cases
by: Mohammad Rezaei Zadeh Rukerd, et al.
Published: (2024-11-01)

Epidemiology and Outcomes of Neonatal Hemophagocytic Lymphohistiocytosis
by: Niveditha Balakumar, et al.
Published: (2022-04-01)